Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says
() -- Moderna (MRNA), TG Therapeutics (TGTX), and Agios Pharmaceuticals (AGIO) will see increased scrutiny during their upcoming Q2 results on ongoing drug launches after their outperformance year to date, BofA Securities said in a note Tuesday. The investment firm said that "beyond topline sales growth, pipeline/regul